G Reynolds
About
In The Last Decade
G Reynolds
37 papers receiving 392 citations
Peers
Comparison fields: 5 of 65
- Cardiology and Cardiovascular Medicine 228
- Epidemiology 107
- Surgery 92
- Radiology, Nuclear Medicine and Imaging 54
- Neurology 46
Countries citing papers authored by G Reynolds
This map shows the geographic impact of G Reynolds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Reynolds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Reynolds more than expected).
Fields of papers citing papers by G Reynolds
This network shows the impact of papers produced by G Reynolds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Reynolds. The network helps show where G Reynolds may publish in the future.
Co-authorship network of co-authors of G Reynolds
This figure shows the co-authorship network connecting the top 25 collaborators of G Reynolds. A scholar is included among the top collaborators of G Reynolds based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Reynolds. G Reynolds is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | Clinical presentation and prognosis in MOG-antibody disease: a UK study (vol 140, pg 12, 2017) | 2 |
| 3 | 5 | |
| 4 | 6 | |
| 5 | 2 | |
| 6 | 2 | |
| 7 | 2 | |
| 8 | 17 | |
| 9 | 33 | |
| 10 | 5 | |
| 11 | 58 | |
| 12 | 10 | |
| 13 | 10 | |
| 14 | 19 | |
| 15 | A haemodynamic dose finding study with a new slow-calcium channel blocker (amlodipine) in coronary artery disease. | 18 |
| 16 | 17 | |
| 17 | 23 | |
| 18 | 9 | |
| 19 | Haemodynamic effects of intravenous nicardipine during upright exercise in patients with stable angina pectoris. | 4 |
| 20 | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.